Drug Profile
Ethinylestradiol/norethisterone - Actavis
Alternative Names: FemHRT; FemHRT® LoLatest Information Update: 18 May 2020
Price :
$50
*
At a glance
- Originator Parke-Davis Pharmaceutical Division
- Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 08 Feb 2019 Chemical structure information added
- 01 Oct 2013 Warner Chilcott has been acquired and merged into Actavis Inc